PBM Issues

Forbes Today , Sen. Bernie Sanders, I-Vt., will haul executives from three insulin manufacturers and three pharmacy benefit managers...

Pharmaceutical companies have cut financial assistance to thwart health-plan tactics The Wall Street Journal It is getting tougher for...

STAT+ House Oversight Committee Chairman James Comer plans to hold a hearing on the results of an investigation into the business...

Healio Key takeaways: The bipartisan plan would decouple pharmacy benefit manager compensation from drug prices, among other reforms. The...

HCP Live Click Here to Watch the Video of Juliana Reed's Talk Juliana Reed, MS, executive director of the Biosimilars Forum, discussed...

Apparently, everyone is for transparency now. So why do employers and their brokers still struggle to understand prescription drug...

CT Mirror “I cannot afford to live.” – Patients are screaming at the outrageous prescription drug costs. The U.S. spends three times more...

Minnesota Reformer Kemper Drug in Elk River recently closed its doors for the last time after having served the community for over 70...

Bipartisan Respondents Strongly Favor Policies that Require PBMs to Provide Value and Lower Drug Costs PBM Accountability Project With...

Axios Pro The Senate Commerce Committee approved the bipartisan Pharmacy Benefit Manager Transparency Act Wednesday on an 18-9 vote. Why...

KIMT3 News Reporter: Annalise Johnson “We care about every part of your healthcare and your life. We do our best for that. We do more...

Rx Healthcare Law Author: Natalia Mazina The California Court of Appeal, First Appellate District has just affirmed the holding of a...

STAT+ News An algorithm, not a doctor, predicted a rapid recovery for Frances Walter, an 85-year-old Wisconsin woman with a shattered...

For Too Long, Insulin Manufacturers and Pharmacy Benefit Managers Have Derived Unjust Economic Benefit from Diabetes Patients and State Taxpayers. Attorney General Landry Seeks to Reverse the Damage Louisiana Independent Pharmacies Association BATON ROUGE, LA (March 15, 2023) – Louisiana Independent Pharmacies Association (LIPA) issued the following statement in response to Attorney General Jeff Landry’s lawsuit naming Sanofi-Aventis U.S., LLC and Novo Nordisk, Inc, two the

Louisiana KTAL News Louisiana Attorney General Jeff Landry announces a new lawsuit aimed at protecting diabetic residents from high costs...

Pharmacy benefit managers say they exclude high-cost drugs and have alternatives on their formularies. Critics say exclusions narrow...

Lexology The Federal Trade Commission (FTC) didn’t mince words. On September 2021, it called out the health app industry for failing to...

While all the major national payers turned a profit last year, one far and away outpaced the competition. Fierce Healthcare UnitedHealth...

CMS rule leaves high out-of-pocket costs, lawsuit argues Aid programs ‘mask’ problem of prices, analysts say Bloomberg Law High drug...

Eli Lilly just announced price cuts of insulin list prices by 70%. Did government just help people? Yes, yes, it did. BIG by Matt Stoller...